Going Public Through a Non-Traditional IPO

May
9
2017

Date: May 9, 2017

Time: 3:30AM - 5:30AM

Location: San Diego, CA

Mintz Levin is hosting a three-part series focused on financing for life sciences companies from initial funding to IPO via private sources, non-traditional IPO's, and traditional IPO's.

In part two of the series, we will focus on Going Public Through a Non-Traditional IPO. Initial Public Offerings are a great way to raise money for your life sciences business. However doing a traditional IPO may be difficult for some earlier stage companies and even seasoned companies in a difficult IPO market. At this program we will discuss alternative ways to raise money in the public markets and create liquidity for you and your investors that may be more suitable for earlier stage life science companies. Come hear our panel explain your options and show you how to maximize your opportunity for a successful transaction.

Professionals

  • Jeremy D. Glaser
  • William C. Hicks

    • Related Industries

  • Life Sciences

    • Speakers

    Jeremy D. Glaser

    Jeremy D. Glaser

    Speaker

    Jeremy D. Glaser is Co-chair of Mintz's Venture Capital & Emerging Companies Practice. He has over three decades of experience guiding life sciences and technology companies in growth and financing strategies, including public offerings, financings, mergers and acquisitions, and SEC compliance.
    William C. Hicks

    William C. Hicks

    Panelist

    William C. Hicks is Co-chair of the Life Sciences Practice Group at Mintz. He has extensive experience representing issuers, investors, and investment banks in structuring and executing IPOs, cross-over investments, alternative public offerings, including APOs, reverse mergers and Form 10 transactions, follow-on public offerings, CMPOs, registered directs, PIPEs, and private placements. His clients include hedge funds, venture capital firms, and private equity firms in customized investments in public companies, including structured PIPEs and registered directs. Bill also represents public companies in public and private financings, SEC compliance, corporate governance, and general counseling.